Feedback activation of STAT3 limits the response to PI3K/AKT/mTOR inhibitors in PTEN-deficient cancer cells

The PI3K/AKT/mTOR signaling pathway is constitutively active in PTEN-deficient cancer cells, and its targeted inhibition has significant anti-tumor effects. However, the efficacy of targeted therapies is often limited due to drug resistance. The relevant signaling pathways in PTEN-deficient cancer c...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jian, Lv, Xiaoye, Guo, Xiutian, Dong, Yanbo, Peng, Peipei, Huang, Fang, Wang, Peng, Zhang, Haoqian, Zhou, Jianguang, Wang, Youliang, Wei, Bo, Shang, Zeng-Fu, Li, Shanhu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801611/
https://www.ncbi.nlm.nih.gov/pubmed/33431808
http://dx.doi.org/10.1038/s41389-020-00292-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7801611/
https://www.ncbi.nlm.nih.gov/pubmed/33431808
http://dx.doi.org/10.1038/s41389-020-00292-w

Ejemplares similares